TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 22 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,673 | -38.8% | 267,821 | +0.0% | 0.00% | – |
| Q2 2023 | $77,906 | -86.5% | 267,719 | -12.5% | 0.00% | – |
| Q1 2023 | $578,015 | +26.0% | 305,828 | -0.7% | 0.00% | – |
| Q4 2022 | $458,852 | -9.5% | 307,954 | +1.3% | 0.00% | – |
| Q3 2022 | $507,000 | -17.0% | 304,088 | -0.4% | 0.00% | – |
| Q2 2022 | $611,000 | -22.5% | 305,410 | +1.9% | 0.00% | – |
| Q1 2022 | $788,000 | -5.6% | 299,621 | -0.6% | 0.00% | – |
| Q4 2021 | $835,000 | -28.0% | 301,484 | +0.7% | 0.00% | – |
| Q3 2021 | $1,159,000 | -39.3% | 299,283 | +1.7% | 0.00% | – |
| Q2 2021 | $1,910,000 | -28.8% | 294,228 | -9.7% | 0.00% | – |
| Q1 2021 | $2,683,000 | -29.6% | 325,970 | 0.0% | 0.00% | – |
| Q4 2020 | $3,813,000 | +13517.9% | 325,970 | +5758.6% | 0.00% | – |
| Q3 2020 | $28,000 | +154.5% | 5,564 | 0.0% | 0.00% | – |
| Q2 2020 | $11,000 | +22.2% | 5,564 | +0.0% | 0.00% | – |
| Q1 2020 | $9,000 | -30.8% | 5,563 | 0.0% | 0.00% | – |
| Q4 2019 | $13,000 | – | 5,563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,518,371 | $9,746,000 | 1.82% |
| Altium Capital Management LP | 785,341 | $3,039,000 | 0.80% |
| Ikarian Capital, LLC | 2,691,110 | $10,415,000 | 0.73% |
| Telemetry Investments, L.L.C. | 130,500 | $505,000 | 0.68% |
| Psagot Value Holdings Ltd. | 143,591 | $556,000 | 0.10% |
| Psagot Value Holdings Ltd. / (Israel) | 143,591 | $556,000 | 0.10% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $110,000 | 0.06% |
| X-Square Capital, LLC | 17,973 | $70,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 85,993 | $333,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 268,301 | $1,038,000 | 0.03% |